A partnership between government agencies is determined to provide researchers with additional dimensions of real-time data for some COVID-19 research.
The relevance of this modification affects health care providers, patients affected by COVID-19 and related conditions, and the life science companies themselves.
The intensity of the global response to the conditions of COVID-19 has prompted a need to address the high levels of burnout experienced by medical professionals.
The FDA staff, researchers, and partners are working virtually around the clock to keep medical professionals updated with the absolute latest information.
This latest document is a series of FDA guidance reports that are created to keep healthcare professionals informed on the latest in the COVID-19 public health emergency (PHE).